
Vali oma silt
näidatakse otse viaalilLaboriaruanne
PDF- Testitud
- Letrozol (Femara) 2.5mg × 100 Tabs
- Labor
- Analiza Białek
- Kuupäev
- October 2026
- Tulemus
- 2.72 mg per tablet (2.5 mg label)
- Tellimuse nr
- Parool
Sõltumatult testitud, kontrollitav parooliga otse laboris.
Letrozol (Femara)
PCT & AI
- Laboris testitud
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
Lühidalt
Letrozol (Femara) arvudes
Põhinäitajad meie leksikonist. Lohista punkti mööda kõverat, et näha, kui palju jääb pärast ühte annust arvutuslikult alles.
Täielik leksikoni artikkelHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~3 days
Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 2 to 4 days, we calculate with the middle.
Half-life
about2-4days
- Class
- Aromatase inhibitornon-steroidal, reversible
- Use
- Oral1-2x per week
- Sizes
- 2.5 mg2 sizes in the shop
What studies show
All 2 sources in the lexiconLetrozole vs tamoxifen in postmenopausal breast cancer (BIG 1-98) (opens in a new tab)
BIG 1-98 Collaborative Group, NEJM, 2005- over99 %Geisler et al., Journal of Clinical Oncology, 2002
Arvustused
Mida kliendid ütlevad
Ainult päris tellimused, milles oli Letrozol (Femara).
Kõik arvustusedTeadmised
Kõik teemal Letrozol (Femara)
Üksikasjalik teave tuleb peagi.
Is letrozole approved?
Yes. In the USA letrozole has been approved as a prescription tablet since 25 July 1997 and ChEMBL lists phase 4 as the highest phase. The large studies concern breast cancer after menopause.
How much does letrozole lower estrogens?
In a study with 12 women who took both drugs one after the other, letrozole suppressed whole-body estrogen production by more than 99.1 percent and anastrozole by 97.3 percent. Estradiol in the blood fell by 87.8 percent with letrozole and estrone sulfate by 98.0 percent.
What did BIG 1-98 show?
Over 8,000 postmenopausal women with hormone-sensitive breast cancer received letrozole or tamoxifen. After five years an estimated 84.0 against 81.4 percent were free of recurrence and the risk of recurrence fell by 19 percent. In return skeletal and cardiac events as well as raised cholesterol were more common with letrozole.
What is known in PCOS?
In a study of 750 women with PCOS trying to conceive letrozole led to a live birth more often than clomiphene (27.5 against 19.1 percent) and to ovulation more often. Hot flushes were more common with clomiphene, fatigue and dizziness with letrozole.
What about bone and blood lipids?
Less estrogen means less protection for bone. In MA.17 5.8 percent on letrozole and 4.5 percent on placebo received a new osteoporosis diagnosis, the difference was not significant. In BIG 1-98 raised cholesterol was more common with letrozole.
How long does letrozole stay in the body?
The US label gives a terminal elimination half-life of about 2 days. According to the label a steady level is only reached after 2 to 6 weeks of daily use.
Võrdlused
Kuidas see võrdub
Seotud
Seotud tooted
Clomid (Clomifen)
Ravimid · Kuurijärgne ravi ja aromataasi inhibiitorid Kuurijärgne ravi ja aromataasi inhibiitorid
2 suurust
Tamoxifen (Nolvadex)
Ravimid · Kuurijärgne ravi ja aromataasi inhibiitorid Kuurijärgne ravi ja aromataasi inhibiitorid
2 suurust
Laboris testitud
Aromasin (Exemestane)
Ravimid · Kuurijärgne ravi ja aromataasi inhibiitorid Kuurijärgne ravi ja aromataasi inhibiitorid
2 suurust
Arimidex (Anastrozole)
Ravimid · Kuurijärgne ravi ja aromataasi inhibiitorid Kuurijärgne ravi ja aromataasi inhibiitorid
2 suurust
Letrozol (Femara)
